首页> 美国卫生研究院文献>other >Biomaterial-Derived Calcium Carbonate Nanoparticles for Enteric Drug Delivery
【2h】

Biomaterial-Derived Calcium Carbonate Nanoparticles for Enteric Drug Delivery

机译:生物材料衍生的碳酸钙纳米颗粒用于肠溶药物递送

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Oral drug delivery systems provide the most convenient, noninvasive, readily acceptable alternatives to parenteral systems. In the current work, eggshell-derived calcium carbonate (CaCO3) nanoparticles were used to develop enteric drug delivery system in the form of tablets. CaCO3 nanoparticles were manufactured using top-down ball-milling method and characterized by X-ray diffractometry (XRD) and transmission electron microscopy (TEM) and loaded with 5-fluorouracil as a model drug. Tablets with varying CaCO3 core and binder compositions were fabricated and coated with Eudragit S100 or Eudragit L100. Suitability for enteric delivery of the tablets was tested by oral administration to rabbits and radiography. Radiograph images showed that the tablet remained in the stomach of the rabbit for up to 3 hours. Further modifications of these biomaterial-derived nanoparticles and the coatings will enable manufacturing of stable formulations for slow or controlled release of pharmaceuticals for enteric delivery.
机译:口服药物递送系统为肠胃外系统提供了最方便,无创,易于接受的替代方法。在当前的工作中,蛋壳衍生的碳酸钙(CaCO3)纳米颗粒被用于开发片剂形式的肠溶药物递送系统。使用自上而下的球磨法制造CaCO3纳米颗粒,并通过X射线衍射(XRD)和透射电子显微镜(TEM)对其进行表征,并加载5-氟尿嘧啶作为模型药物。制备具有变化的CaCO3核和粘合剂组成的片剂,并用Eudragit S100或Eudragit L100包衣。通过对兔子口服给药和放射照相法测试了片剂的肠内递送的适用性。射线照片显示该片剂在兔子的胃中保留了长达3个小时。这些生物材料衍生的纳米颗粒和包衣的进一步修饰将使得能够制造稳定的制剂,以缓慢或受控地释放用于肠递送的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号